Via Nova Therapeutics uses CDD Vault to support global collaboration

In this case study, Collaborative Drug Discovery showcases how Via Nova Therapeutics implemented CDD Vault^® to securely manage both its internal and external biological and chemical data. Via Nova Therapeutics utilizes cutting-edge drug discovery methods, including phenotypic and biochemical screening, structure-based drug design, and targeting essential host factors, to identify novel antivirals for the specific infections it studies.